Last updated on October 2018

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Brief description of study

The study will evaluate the efficacy and safety of imipenem+cilastatin/relebactam (IMI/REL, MK-7655A) in Japanese participants with complicated intra-abdominal infection (cIAI) or complicated urinary tract infection (cUTI).

Clinical Study Identifier: NCT03293485

Contact Investigators or Research Sites near you

Start Over

Toll Free Number

Suwa Red Cross Hospital ( Site 1705)
Suwa, Japan